Clinical Trials for Refractory Poorly Differentiated Thyroid Gland Carcinoma

Find clinical trials for refractory poorly differentiated thyroid gland carcinoma. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer

NCT ID: NCT06959641

This clinical trial is studying a medication called XL092 for patients with certain types of thyroid cancer that have not responded to previous treatment with a radioactive iodine therapy. Specific...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions